January 13, 2026

Agios Pharmaceuticals, Inc. (AGIO) Stock Analysis: Exploring a 29.77% Potential Upside in Biotechnology

Agios Pharmaceuticals, Inc. (NASDAQ: AGIO) is making waves in the biotechnology sector with its innovative approach to tackling metabolic disorders. With a market capitalization of $1.65 billion, this Cambridge, Massachusetts-based..

Integra LifeSciences Holdings C (IART): Investor Outlook with a 17.87% Potential Upside

Integra LifeSciences Holdings Corporation (NASDAQ: IART), a prominent player in the medical devices sector, presents an intriguing opportunity for investors navigating the healthcare landscape. With a market capitalization of $1.02..

Evotec SE (EVO) Stock Analysis: Exploring a Potential 47.54% Upside in a Challenging Landscape

Evotec SE (EVO), a notable player in the healthcare sector, specifically in the specialty and generic drug manufacturing industry, operates on a global scale with its headquarters in Hamburg, Germany...

Premier, Inc. (PINC): Investor Outlook Amidst 2.97% Dividend Yield and Zero Buy Ratings

Premier, Inc. (NASDAQ: PINC), a noteworthy player in the healthcare sector, specializes in health information services. With a market capitalization of $2.34 billion, Premier operates as a healthcare improvement company..

AdaptHealth Corp. (AHCO) Stock Analysis: Exploring a 25% Potential Upside with Strong Buy Ratings

AdaptHealth Corp. (NASDAQ: AHCO), a prominent player in the healthcare sector specializing in medical devices, is capturing the attention of investors with its promising growth prospects and robust market presence...

Kymera Therapeutics (KYMR): Investor Outlook on Biotech’s 59.75% Upside Potential

Kymera Therapeutics, Inc. (NASDAQ: KYMR), headquartered in Watertown, Massachusetts, is capturing the attention of investors with its promising biotechnology breakthroughs and substantial upside potential. As a clinical-stage biopharmaceutical company, Kymera..

Opko Health, Inc. (OPK) Stock Analysis: Exploring a 167% Potential Upside for Investors

Opko Health, Inc. (NASDAQ: OPK), a prominent player in the healthcare sector specializing in diagnostics and pharmaceuticals, is capturing investor attention with a substantial potential upside of 167.54%. With a..

Addus HomeCare Corporation (ADUS) Stock Analysis: A Strong Buy with a 26.56% Upside Potential

Addus HomeCare Corporation (NASDAQ: ADUS), a key player in the healthcare sector, specifically within the medical care facilities industry, has been capturing investor attention with its substantial growth potential. With..

Healthcare Services Group, Inc. (HCSG) Stock Analysis: Potential Upside and Analyst Ratings

Healthcare Services Group, Inc. (NASDAQ: HCSG) has been gaining attention in the healthcare sector, particularly in the medical care facilities industry. Based in Bensalem, Pennsylvania, the company specializes in providing..

Pulse Biosciences, Inc (PLSE) Stock Analysis: Exploring a 51% Potential Upside

Pulse Biosciences, Inc. (NASDAQ: PLSE), a pioneering company in the healthcare sector, is drawing attention from investors with its cutting-edge innovations in bioelectric medicine. Specializing in medical instruments and supplies,..

MannKind Corporation (MNKD) Stock Analysis: 66.57% Potential Upside Captivates Investors

MannKind Corporation (NASDAQ: MNKD), a prominent player in the biotechnology sector, offers a compelling opportunity for investors, bolstered by a promising 66.57% potential upside based on analyst ratings. With a..

LivaNova PLC (LIVN) Stock Analysis: Exploring a 17% Potential Upside in the Medical Device Sector

LivaNova PLC (NASDAQ: LIVN), a leading player in the medical technology space, is currently garnering significant attention from investors with its promising 17% potential upside. Headquartered in London, United Kingdom,..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: A Promising 20% Upside in Biotech Innovation

Protagonist Therapeutics, Inc. (NASDAQ: PTGX) is currently capturing the attention of investors with its promising pipeline of peptide therapeutics aimed at addressing complex hematology and blood disorders, as well as..

Phreesia, Inc. (PHR) Investor Outlook: A 70% Potential Upside in the Healthcare SaaS Space

Phreesia, Inc. (NYSE: PHR) is making waves in the health information services sector with its innovative SaaS-based solutions designed to streamline patient and healthcare provider interactions. With a market capitalization..

BioCryst Pharmaceuticals (BCRX) Stock Analysis: A Rare Disease Innovator with 189% Upside Potential

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) is making waves in the biotechnology sector, primarily due to its focus on developing treatments for rare diseases. With a market capitalization of $1.49 billion,..

Janux Therapeutics, Inc. (JANX) Stock Analysis: A High-Stakes Bet with 358% Potential Upside

For investors seeking high-growth opportunities in the biotechnology sector, Janux Therapeutics, Inc. (NASDAQ: JANX) presents an intriguing proposition. A clinical-stage biopharmaceutical company, Janux is at the forefront of developing innovative..

Certara, Inc. (CERT) Stock Analysis: A Healthcare Innovator with 31.79% Potential Upside

Certara, Inc. (CERT) is making waves in the healthcare sector with its innovative approach to biosimulation and model-informed drug development. Based in Radnor, Pennsylvania, Certara provides a suite of technology-enabled..

Astrana Health Inc. (ASTH) Stock Analysis: Significant Revenue Growth and a Promising 26% Upside

Astrana Health Inc. (NASDAQ: ASTH), a prominent player in the healthcare sector, is making waves with its robust revenue growth and substantial potential upside. With a market capitalization of $1.47..

Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a 25.71% Upside Potential in the Healthcare Sector

Kestra Medical Technologies, Ltd. (NASDAQ: KMTS) is capturing investor attention in the healthcare arena, particularly within the Medical Instruments & Supplies industry. With a market cap standing at $1.37 billion,..

Harrow, Inc. (HROW) Stock Analysis: A 47.63% Potential Upside in the Healthcare Sector

Harrow, Inc. (HROW), a distinguished player in the healthcare sector, particularly within the niche of specialty and generic drug manufacturing, has been capturing investor attention with its recent financial and..

Search

Funds

January 13, 2026

Search

Funds

January 13, 2026

FTSE 100

Funds